SOYDAL, Ç. Et Al. 2019. Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma. MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.28, no.2 , 69-75.

SOYDAL, Ç., ÖZKAN, E., Nak, D., ELHAN, A. H., KÜÇÜK, N. Ö., & KIR, K. M., (2019). Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma. MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.28, no.2, 69-75.

SOYDAL, ÇİĞDEM Et Al. "Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma," MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.28, no.2, 69-75, 2019

SOYDAL, ÇİĞDEM Et Al. "Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma." MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.28, no.2, pp.69-75, 2019

SOYDAL, Ç. Et Al. (2019) . "Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma." MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.28, no.2, pp.69-75.

@article{article, author={ÇİĞDEM SOYDAL Et Al. }, title={Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma}, journal={MOLECULAR IMAGING AND RADIONUCLIDE THERAPY}, year=2019, pages={69-75} }